Mattel CEO says toy manufacturing won’t come to America, but price hikes will

Mattel CEO says toy manufacturing won’t come to America, but price hikes will


Mattel CEO Ynon Kreiz: Cheaper to manufacture toys outside the U.S. even with tariffs in place

One of the goals of President Donald Trump’s 145% tariffs against China is to drive manufacturing back to America. But the odds of that are low, at least when it comes to toys.

“We don’t see that happening,” Mattel CEO Ynon Kreiz said on CNBC’s “Squawk Box” Tuesday, less than a day after the company withdrew annual financial targets.

“We need to remember that a significant part of toy creation happens in America,” he said. “Design, development, product engineering, brand management all happens in America. Making product, producing product in other countries, allows us to create quality products at affordable price points.”

Mattel has been diversifying its global manufacturing for nearly a decade in an effort to reduce its dependence on China. By the end of the year, less than 40% of Mattel’s product will be sourced from the country. Kreiz noted that in two years, no country will represent more than 25% of Mattel’s sourcing.

The new and old versions of the classic Barbie dolls are on display at Mattel Design Center in El Segundo, California, on Feb. 22, 2024.

Mario Anzuoni | Reuters

In the meantime, Mattel is taking mitigating actions to fully offset costs associated with Trump’s trade war with China, including raising prices in the U.S., while aiming to keep the cost of many toys low.

The company is expecting to keep between 40% and 50% of its products under $20, according to Roth analyst Eric Handler.

“This is something we are committed to do,” Kreiz said. “To continue to create quality product and find the right balance of price and value all in the service of the consumer.”

Since the tariffs were announced on April 2, Mattel’s stock is down about 19%.



Source

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Business

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Thomas Fuller | SOPA Images | Lightrocket | Getty Images UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday. The official, who requested anonymity before discussing sensitive information, confirmed the agency […]

Read More
Home sellers are relisting properties at fastest pace in a decade, but spring supply is still low
Business

Home sellers are relisting properties at fastest pace in a decade, but spring supply is still low

A “For Sale” sign outside a house in the Capitol Hill neighborhood of Washington, DC, US, on Tuesday, Aug. 12, 2025. Al Drago | Bloomberg | Getty Images The all-important spring housing market is off and running, and while the pace isn’t expected to be strong, there are signs of optimism, at least among sellers. […]

Read More
Victoria’s Secret posts longest sales growth streak in four years as shoppers return to Pink brand
Business

Victoria’s Secret posts longest sales growth streak in four years as shoppers return to Pink brand

Victoria’s Secret store in New York. Scott Mlyn | CNBC Victoria’s Secret topped expectations during its holiday quarter and forecasted a better-than-expected year for sales growth on Thursday as CEO Hillary Super’s turnaround plan continues to resonate with shoppers.   The legacy bra and underwear company beat Wall Street’s expectations on both the top and bottom […]

Read More